Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.

CONCLUSIONS: Through machine learning-based integration of drug phenotypic, therapeutic, structural, and genomic similarities, we demonstrated that HNAI is promising for uncovering DDIs in drug development and postmarketing surveillance. PMID: 24644270 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24644270?dopt=Abstract

Source: Journal of the American Medical Informatics Association - March 18, 2014 Category: Information Technology Authors: Cheng F, Zhao Z Tags: J Am Med Inform Assoc Source Type: research